Analytical Data
-
Gene name
KIAA1109
- Application
-
Alternative Names
KIAA1109; FSA; KIAA1371; Transmembrane protein KIAA1109; Fragile site-associated protein
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q2LD37
-
Expression Region
1-191aa
-
AA Sequence
MQLDFKSIHVQEPQEPSLQDASLKPKVECSVVTEFTDHICVTMDAELIMFLHDLVSAYLKEKEKAIFPPRILSTRPGQKSPIIIHDDNSSDKDREDSITYTTVDWRDFMCNTWHLEPTLRLISWTGRKIDPVGVDYILQKLGFHHARTTIPKWLQRGVMDPLDKVLSVLIKKLGTALQDEKEKKGKDKEEH
-
Molecular Weight
48.5 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
KIAA1109, a gene located on chromosome 11, encodes a protein that has garnered significant attention due to its potential involvement in various biological processes and diseases. Initially identified through genomic studies, KIAA1109 has been linked to cellular mechanisms such as cell proliferation, differentiation, and immune response regulation. Recent investigations have revealed that the KIAA1109 protein may play a crucial role in the development and maintenance of certain tissues, as well as in the pathophysiology of disorders including cancer and autoimmune diseases. The focus on recombinant KIAA1109 protein aims to elucidate its functional properties and to explore its interactions within biological pathways. Advances in recombinant DNA technology have enabled the production of this protein in substantial quantities, facilitating in vitro studies. These studies aim to characterize the protein's structure, binding affinities, and enzymatic activities, advancing our understanding of its role in health and disease. Furthermore, uncovering the functional implications of KIAA1109 may pave the way for novel therapeutic strategies, targeting its pathways to treat related diseases. Overall, the investigation of recombinant KIAA1109 protein is vital for comprehending its biological significance and potential as a therapeutic target in medicine.
